click below
click below
Normal Size Small Size show me how
HIV ARV therapy
| Question | Answer |
|---|---|
| Zidovudine | NRTI |
| Abacavir | NRTI |
| Lamivudine | NRTI |
| Emtricitabine | NRTI |
| Didanosine | NRTI |
| Stavudine | NRTI |
| Tenofovir | NRTI (nucleoTide) |
| Class toxicities: lactic acidosis, hepatomegaly | NRTI |
| AE: mostly myelosuppression; anemia, neutropenia, HA, malaise | ZIdovudine (AZT) |
| BBW: non-cirrhotic portal HTN; AE: pancreatitis, CD4 toxicity with Tenofovir (TDF) | Didanosine (ddI) |
| AE: peripheral neuropathy, mitochondrial toxicities, lipoatrophy | Stavudine (d4T) |
| benign drugs with little toxicities; HA, N/V/D | Lamivudine (3TC) Emtricitabine (FTC) |
| hypersensitivity--check allele; doesn't work viral load >100,00, penetrates CNS well | Abacavir (ABC) |
| renal dysfunction--Fanconi's syndrome | Tenofovir (TDF) |
| drugs with activity against HBV | Tenofovir Lamivudine Emtricitabine |
| Efavirenz | NNRTI |
| Nevirapine | NNRTI |
| Delavirdine | NNRTI |
| Etravirine | NNRTI |
| Rilpivirine | NNRTI |
| class toxicites: hepatotoxicity, rash | NNRTIs |
| K103 mutations is responsible for resistance in these ARVs | Efavirenz Nevirapine Delavirdine |
| Contraindicated with PPIs | Rilpivirine |
| Atazanavir | PI |
| Darunavir | PI |
| Nelfinavir | PI |
| Saquinavir | PI |
| Ritonavir | PI |
| Indinavir | PI |
| Lopinavir | PI |
| Tipranavir | PI |
| Fosamprenavir | PI |
| AE: Jaundice, scleral icterus, cholelithiasis, nephrolithiasis, requires acidic pH | Atazanavir |
| AE: N/V/D; take with food to increase bioavail | Darunavir |
| rarely used; really bad diarrhea | Nelfinavir |
| rarely used; prolong QT interval | Saquinavir |
| not an active PI anymore; pharmaco-enhancer | Ritonavir |
| not used often; nephrolithiasis | Indinavir |
| has Ritonavir in formulation; good pregnancy data | Lopinavir |
| salvage drug--higher dose; AE: intracranial bleed | Tipranavir |
| Raltegravir | Intergrase inhibitor |
| AE: severe rash, CPK | Raltegravir |
| Maraviroc | Entry inhibitor |
| must be CCR5 dominant | Maraviroc |
| BBW: hepatotoxicity | Maraviroc |
| Fusion inhibitor; last line therapy; no DDI because it's a very large peptide | Fuzeon |
| Sulfa allergy caution use of: | Darunavir Fosamprenavir Tipranavir |
| AE: depression (Psychiatric disorders), insomnia, HA, rash | Rilpivirine |